Otsuka Pharmaceutical’s kidney disease drug has hit the primary endpoint of a phase 3 trial by demonstrating in an interim analysis the reduction of patients’ urine protein-to-creatine ratio (UPCR) ...
Kidneys are vital organs responsible for filtering waste products, including creatinine, from the blood. Creatinine is a byproduct of muscle metabolism and serves as a key indicator of kidney function ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback